News and Updates

New prediction markets now allow users to bet on the success of FDA drug trials. Explore the implications for biotech innovation and regulatory integrity.

A new oral drug successfully prevents chemotherapy-induced low platelet counts, helping cancer patients stay on their vital treatment schedules.

A private university has launched clinical trials for a new dengue vaccine. Discover how this research could shape future immunization against the virus.

Massive Bio and FOMAT Medical Research partner to use AI-driven prescreening tools to help cancer patients find and enroll in critical clinical trials.

Nuvation Bio moves its glioma therapy to Phase III trials after positive three-year data shows improved patient survival and strong clinical efficacy.

Samsung Biologics plans a $1.8B acquisition of Swiss CDMO PolyPeptide, marking a strategic shift to expand its production capabilities into peptide medicines.

The CDSCO has authorized a Phase III trial for Enlicitide Decanoate. Learn about this critical step in the drug's clinical development and safety review.

New clinical trial results reveal how liquid biopsy and molecular profiling could transform the diagnostic pathway for difficult-to-treat unknown cancers.

Dianthus Therapeutics stock surges as the company launches a pivotal Phase 3 clinical trial for its lead autoimmune drug candidate. Read the latest update.

Argo Biopharma has dosed the first patient in a Phase I trial for BW-41012, a novel siRNA therapy targeting Factor XI for safer anticoagulant treatment.